- Home
- EVF vs SAVA Comparison
EVF vs SAVA Comparison
Compare EVF & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- SAVA
- Stock Information
- Founded
- EVF 1998
- SAVA 1998
- Country
- EVF United States
- SAVA United States
- Employees
- EVF N/A
- SAVA N/A
- Industry
- EVF Investment Managers
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- EVF Finance
- SAVA Health Care
- Exchange
- EVF Nasdaq
- SAVA Nasdaq
- Market Cap
- EVF 101.0M
- SAVA 102.4M
- IPO Year
- EVF N/A
- SAVA N/A
- Fundamental
- Price
- EVF $5.46
- SAVA $3.96
- Analyst Decision
- EVF
- SAVA Buy
- Analyst Count
- EVF 0
- SAVA 2
- Target Price
- EVF N/A
- SAVA $5.00
- AVG Volume (30 Days)
- EVF 93.3K
- SAVA 3.5M
- Earning Date
- EVF 01-01-0001
- SAVA 11-06-2025
- Dividend Yield
- EVF 10.68%
- SAVA N/A
- EPS Growth
- EVF N/A
- SAVA N/A
- EPS
- EVF 0.94
- SAVA N/A
- Revenue
- EVF N/A
- SAVA N/A
- Revenue This Year
- EVF N/A
- SAVA N/A
- Revenue Next Year
- EVF N/A
- SAVA N/A
- P/E Ratio
- EVF $6.74
- SAVA N/A
- Revenue Growth
- EVF N/A
- SAVA N/A
- 52 Week Low
- EVF $5.20
- SAVA $1.15
- 52 Week High
- EVF $6.84
- SAVA $33.98
- Technical
- Relative Strength Index (RSI)
- EVF 47.26
- SAVA 56.66
- Support Level
- EVF $5.41
- SAVA $4.25
- Resistance Level
- EVF $5.48
- SAVA $4.69
- Average True Range (ATR)
- EVF 0.05
- SAVA 0.39
- MACD
- EVF -0.00
- SAVA 0.00
- Stochastic Oscillator
- EVF 53.44
- SAVA 43.75
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.